Primary lymphoma of the brain in a young man whose brother died of hemophagocytic lymphohistiocytosis: Case report

Srpski Arhiv za Celokupno Lekarstvo

Volumn 143, Issue 1-2, 2015, Pages 63-67

  Dšoljić, Eleonora ^a,b   Stošić Opinćal, Tatjana ^a,b   Skender Gazibara, Milica ^a   Terzić, Tatjana ^a   Mihaljević, Biljana ^a,b   Milivojević, Goran ^a,b   Kostić, Vladimir ^a,b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Hemophagocytic lymphohistiocytosis; Perforin mutation; Primary aggressive diffuse large B cell CNS lymphoma

Indexed keywords

PERFORIN;

ADULT; BRAIN NEOPLASMS; CASE REPORT; GENETIC SCREENING; GENETICS; HEMOPHAGOCYTIC SYNDROME; HUMAN; LYMPHOMA; MALE; MUTATION; SIBLING;

ADULT; BRAIN NEOPLASMS; GENETIC TESTING; HUMANS; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; LYMPHOMA; MALE; MUTATION; PERFORIN; SIBLINGS;

EID: 84924362559     PISSN: 03708179     EISSN: None     Source Type: Journal    
DOI: 10.2298/SARH1502063D     Document Type: Article

References (26)

1. Gallop-Evans E. Primary central nervous system lymphoma. Clin Oncol (R Coll Radiol). 2012; 24:329-38.
2. Lai R, Rosenblum MC, DeAngelis LM. Primary CNS lymphoma: A whole brain disease? Neurology. 2002; 59:1557-62.
3. Montesinos-Rongen M, Siebert R, Deckert M. Primary lymphoma of the central nervous system: just DLBCL or not? Blood. 2009;113:7e10.
4. Nastoupil LJ, Rose AC, Flowers CR. Diffuse large B-cell lymphoma: current treatment approaches. Oncology. 2012; 26:488-95.
5. Rubenstein JL, Fridlyand J, Shen A, Aldape K, Ginzinger D, Batchelor T, et al. Gene expression and angiotropism in primary CNS lymphoma. Blood. 2006; 107:3716-23.
6. Fisman DN. Hemophagocytic syndromes and infection. Emerg Infect Dis. 2000; 6:601-8.
7. Aggarwal D, Gupta R, Singh S, Gupta K, Kudesia M. Hemophagocytic lymphohistiocytosis in B-cell lymphoproliferative disorder: Report of a rare association. Indian J Hematol Blood Transfus. 2010; 26:74-6.
8. Balwierz W, Czogata M, Czepko E. Anaplastic large cell lymphoma associated with hemophagocytic lymphohistiocytosis: a case report and review of the literature. Przegl Lek. 2010; 67:436-8.
9. Cwiklinska M, Czogata M, Balwierz W, Hnatko-Kotacz M, Moryl-Bujakowska A, Malinowska I, et al. Hemophagocytic syndrome in children with different underlying conditions. Przegl Lek. 2010;67:430-5.
10. Nakamura S, Murase T, Kinoshita T. Intravascular large B-cell lymphoma: the heterogeneous clinical manifestations of its classical and hemophagocytosis-related forms. Haematologica. 2007; 92:434-6.
11. Altaf A, Arteaga GM, Joshi AY, Rodriguez V. Diffuse large B-cell lymphoma in an adolescent female presenting with Epstein-Barr virus-driven hemophagocytic lymphohistiocytosis: a case report. J Med Case Rep. 2012; 6:141.
12. Kridel R, Dietrich PY. Prevention of CNS relapse in diffuse large B-cell lymphoma. Lancet Oncol. 2011; 12:1258-66.
13. Min M, Lin L, Bi CF, Wang XQ, Luo TY, Zhao S, et al. Analysis of the immunohistochemical subtypes and prognosis of primary diffuse large B cell lymphoma of the central nervous system. ZhonghuaZhong Liu ZaZhi. 2012; 34:110-6.
14. Hill Q, Owen R. CNS prophylaxis in lymphoma: who to target and what therapy to use. Blood Rev. 2006; 20:319-32.
15. Kwong Y, Yeung D, Chan J. Intrathecal chemotherapy for hematologic malignancies: drugs and toxicities. Ann Hematol. 2009; 88:193-201.
16. Blum K, Lozanski G, Byrd J. Adult Burkitt leukemia and lymphoma. Blood. 2004; 104:3009-20.
17. Deckert M, Paulus W. Malignant lymphomas. In: Louis DN, Ohgaki HOD, editors.WHO Classification of Tumours of the Central Nervous System. Lyon, France: Wiestler & W. K. Cavenee, IARC; 2007. p.188-192.
18. Motomura K, Natsume A, Fujii M, Ito M, Momota H, Wakabayashi T. Long-term survival in patients with newly diagnosed primary central nervous system lymphoma treated with dexamethasone, etoposide, ifosfamide and carboplatin chemotherapy and whole-brain radiation therapy. Leuk Lymphoma. 2011; 52:2069-75.
19. Deckert MA, Engert A, Brück W, Ferreri AJ, Finke J, Illerhaus G, et al. Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphoma. Leukemia. 2011; 25(12):1797-807.
20. Montesinos-Rongen M, Brunn A, Bentink S, Basso K, Lim WK, Klapper W, et al. Gene expression profiling suggests primary central nervous system lymphomas to be derived from a late germinal center B cell. Leukemia. 2008; 22:400-5.
21. Baraniskin A, Deckert D, Schulte-Altedorneburg G, Schlegel U, Schroers R. Current strategies in the diagnosis of diffuse large B-cell lymphoma of the central nervous system. Br J Haematol. 2011; 156:421-32.
22. Maeshima AM, Taniguchi H, Fukuhara S, Morikawa N, Munakata W, Maruyama D, et al. Bcl-2, Bcl-6, and IPI are prognostic indicators in patients with DLBCL treated with rituximab-containing chemotherapy. Cancer Sci. 2012; 103(10):1898-904.
23. Kim JE, Yoon DH, Kim S, Lee DH, Kim JH, Yoon YH, et al. Relapse pattern and prognostic factors for patients with primary central nervous system lymphoma. Korean J Hematol. 2012; 47:60-6.
24. Ferreri AJM, Marturano E. Primary CNS lymphoma. Best Practice & Research Clinical Haematology. 2012; 25:119-30.
25. Zhang K, Filipovich AH, Johnson J, Marsh RA, Villanueva J. Hemophagocytic lymphohistiocytosis, familial. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews®. Seattle, WA: University of Washington, Seattle and National Center for Biotechnology Information; 2013. Availble from: http://www.ncbi.nlm.nih.gov/books/NBK1444/.
26. Trapani JA, Thia KY, Andrews M, Davis ID, Gedye C, Parente P, et al. Human perforin mutations and susceptibility to multiple primary cancers. Oncoimmunology. 2013; 2:e24185.